Responses
Immunotherapy biomarkers
Original research
Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer: a secondary analysis of a randomized clinical trial
Compose a Response to This Article
Other responses
No responses have been published for this article.
